Therefore, the hypothesis that this polymorphism may be significant in tumor development could not be excluded, and further investigation of this polymorphism in tumor tissue is required.
← all excerpts
SLC23A2-05 (rs4987219) and KRAS-LCS6 (rs61764370) polymorphisms in patients with squamous cell carcinoma of the head and neck.
1
—
—